- Home
- VLY vs KLTOW Comparison
VLY vs KLTOW Comparison
Compare VLY & KLTOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VLY
- KLTOW
- Stock Information
- Founded
- VLY 1927
- KLTOW N/A
- Country
- VLY United States
- KLTOW United States
- Employees
- VLY N/A
- KLTOW 3
- Industry
- VLY Major Banks
- KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VLY Finance
- KLTOW Health Care
- Exchange
- VLY Nasdaq
- KLTOW Nasdaq
- Market Cap
- VLY N/A
- KLTOW N/A
- IPO Year
- VLY N/A
- KLTOW 2022
- Fundamental
- Price
- VLY $9.64
- KLTOW $0.24
- Analyst Decision
- VLY Buy
- KLTOW
- Analyst Count
- VLY 13
- KLTOW 0
- Target Price
- VLY $10.54
- KLTOW N/A
- AVG Volume (30 Days)
- VLY 10.8M
- KLTOW N/A
- Earning Date
- VLY 07-24-2025
- KLTOW N/A
- Dividend Yield
- VLY 4.55%
- KLTOW N/A
- EPS Growth
- VLY N/A
- KLTOW N/A
- EPS
- VLY 0.69
- KLTOW N/A
- Revenue
- VLY $1,520,316,000.00
- KLTOW N/A
- Revenue This Year
- VLY $34.12
- KLTOW N/A
- Revenue Next Year
- VLY $8.89
- KLTOW N/A
- P/E Ratio
- VLY $13.98
- KLTOW N/A
- Revenue Growth
- VLY N/A
- KLTOW N/A
- 52 Week Low
- VLY $6.56
- KLTOW N/A
- 52 Week High
- VLY $11.10
- KLTOW N/A
- Technical
- Relative Strength Index (RSI)
- VLY 69.30
- KLTOW N/A
- Support Level
- VLY $8.82
- KLTOW N/A
- Resistance Level
- VLY $9.05
- KLTOW N/A
- Average True Range (ATR)
- VLY 0.22
- KLTOW 0.00
- MACD
- VLY 0.09
- KLTOW 0.00
- Stochastic Oscillator
- VLY 97.01
- KLTOW 0.00
About KLTOW Klotho Neurosciences Inc. Warrant
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.